12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

MM-111 regulatory update

Merrimack said FDA granted Orphan Drug designation for MM-111 to treat gastric and gastroesophageal junction cancers. The...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >